Psychedelic Business News Spotlight: March 5, 2021
This week in psychedelic business news: two companies enter the Canadian Stock Exchange, AI comes to psychedelic treatment, and psilocybin comes to Brazil.
Day: March 5, 2021
Psychedelic Biotech Company Atai Life Sciences Valued At $2 Billion
Biotech company Atai Life Sciences has earned a $2 billion valuation for its work in developing psychedelic treatments for mental health issues.
End of content
End of content